1. Confidential Information Taken by Employees or Suppliers
An NDA and a trade secret claim protect different interests. The claimant must identify the information, establish its protection, and prove unauthorized acquisition, disclosure, or use.
Former Employees or Contractors Take Manufacturing Data
Under the Defend Trade Secrets Act, the owner must take reasonable secrecy measures. The information must derive economic value from being neither generally known nor readily ascertainable through proper means. It must relate to a product or service used, or intended for use, in interstate or foreign commerce.
New York uses common law for state trade secret claims rather than the Uniform Trade Secrets Act. Access logs, restricted folders, NDAs, and departure records help show what remained secret and how it moved. Lawful reverse engineering is not an improper means of acquisition under the DTSA.
Suppliers Disclose or Reuse Confidential Specifications
Authorized access does not necessarily permit reuse for another customer. Permitted-use clauses and confidentiality exceptions determine the contractual limits. Under the governing state law, a contract claim may survive even if the information is not a trade secret. Preserve the agreement and transmission records.
2. Patent Claims and Copied Technical Documents
Patent and copyright infringement claims arise under federal law. Using a process and copying its documentation require separate analyses because they concern different protected rights.
A Competitor Uses a Patented Manufacturing Process
Process patent infringement analysis compares the accused conduct with the construed claim limitations. A similar finished product alone may not establish that the claimed steps were performed.
Under 35 U.S.C. § 271(g), unauthorized U.S. .mports, sales, offers for sale, or use of products made by a U.S.-patented process can constitute infringement. Exceptions include products materially changed by later processes or reduced to trivial, nonessential components of another product.
Proprietary Drawings, Code, or Manuals Are Copied
Technical drawing infringement requires separating original expression from dimensions, functional requirements, and standard features. Copyright protects original expression, not the underlying manufacturing method.
For U.S. .orks, registration or refusal generally precedes suit. Timely registration affects statutory damages and attorney’s fees. Reverse engineering does not automatically qualify as fair use under 17 U.S.C. § 107.
3. Industrial Branding and Online Counterfeit Sales
Confusing branding and abusive domains involve different legal tests. Product resemblance alone does not establish either claim.
Competitors Copy Marks, Packaging, or Product Appearance
Likelihood of confusion depends on the applicable court’s factors, including mark similarity, related goods, and purchasing conditions. 15 U.S.C. § 1114 covers registered marks; § 1125(a) can cover qualifying unregistered marks and trade dress.
Trade dress must be nonfunctional. Product-design trade dress also requires secondary meaning: buyers must associate the design with a particular source. Dilution requires fame among the general consuming public, not merely recognition within an industrial niche.
Domains or Marketplaces Distribute Counterfeit Goods
The Anticybersquatting Consumer Protection Act requires elements including bad-faith intent to profit from a protected mark. Under the UDRP, the claimant must show confusing similarity, the registrant’s lack of rights or legitimate interests, and bad-faith registration and use. Relief is transfer or cancellation, not damages.
Marketplace reports may remove listings under platform policies but do not decide liability or award compensation. Preserve listing URLs, timestamps, seller identifiers, purchase records, and product samples before content disappears.
4. Joint Development Creates Conflicting Ownership Claims
Participation in a project does not answer who owns the resulting rights. Inventorship, assignments, preexisting technology, and retained licenses require separate review.
Development Partners Dispute Ownership or Licensing Rights
Patent inventorship turns on contributions to the claimed invention; funding alone does not make a party an inventor. Patent ownership may pass through written assignments.
Absent a contrary agreement, 35 U.S.C. § 262 permits each joint patent owner to make, use, sell, offer to sell, or import the invention without the others’ consent or accounting. Contractual restrictions and licensing terms may change that position. Preserve signed assignments, invention records, and field-of-use provisions.
5. Evidence and Remedies Depend on the Claim
The available relief depends on the right, the conduct, and the proven harm. Stopping production and recovering lost sales require different supporting evidence.
Preserving Evidence without Publicly Revealing Secrets
Once litigation is reasonably anticipated, preserve relevant messages, cloud logs, and file versions. Federal Rule 26(c) permits protective orders on a showing of good cause. A discovery confidentiality designation does not automatically justify sealing a court filing.
Matching Relief to the Evidence
| Dispute | Evidence Affecting Relief |
|---|---|
| Trade secret misuse | Secrecy measures, unauthorized conduct, and attributable loss or unjust enrichment |
| Patent infringement | Claim coverage, infringing acts, and royalty or lost-profit evidence |
| Confidentiality breach | Contract scope, breach, causation, and recoverable loss |
Injunctions require the applicable legal showing; suspected misuse alone is insufficient.
Additional Questions about Timing and Costs
Does negotiation suspend the filing deadline?
Generally, no. The DTSA allows three years from actual or reasonably discoverable misappropriation. State claims have separate periods. Settlement talks alone generally do not pause them.
Does winning automatically result in attorney’s fees?
No. Fee recovery depends on the claim, governing statute, and any enforceable contract provision. A successful claim alone does not create a uniform right to reimbursement.
20 Jan, 2026
